FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine, namely to haematology and can be used for treatment of hematopoietic erythroid lineage depression in cytostatic myelosuppression. It is ensured by introduction of Cyproheptadine in a dose 30 mg/kg, 30 minutes prior to introduction of a cytostatic agent. The next days, cytostatic action is followed with introduction of Recormone dosed 10 UN/a mouse once a day within 5 days.
EFFECT: method provides effect potentiation and reduction of adverse reaction of Recormone, ensuring normalised content of erythroid cells in peripheral blood.
1 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION PREVENTING DEVELOPMENT OF DEPRESSION OF ERITHROID HEMATOPOIESIS SHOOT WITH INTRODUCTION OF CYTOSTATIC | 2007 |
|
RU2354376C1 |
| MEDICATION PREVENTING DEVELOPMENT OF DEPRESSION OF HEMATOPOIESIS ERYTHROID LINEAGE IN CASE OF CYTOSTATIC MYELO DEPRESSIONS | 2007 |
|
RU2351333C1 |
| METHOD OF GRANULOCYTOPOIESIS DEPRESSION CORRECTION IN CYTOSTATIC ACTION | 2008 |
|
RU2366422C1 |
| METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
| METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
| METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
| MEDICINAL AGENT STIMULATING ERYTHROIDE HEMOPOIESIS GERM AT CYTOSTATIC MYELODEPRESSION STATES | 1992 |
|
RU2061475C1 |
| HAEMOSTIMULATING AGENT | 2013 |
|
RU2535021C1 |
| METHOD FOR SIMULATING CHRONIC CYTOSTATIC MYELOSUPPRESSION | 2012 |
|
RU2488890C1 |
| HEMOSTIMULATING MEDICATION | 2012 |
|
RU2505308C1 |
